Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer would result in equivalent surv...
मुख्य लेखकों: | Jaime D. Lewis, Anees B. Chagpar, Elizabeth A. Shaughnessy, Jacob Nurko, Kelly McMasters, Michael J. Edwards |
---|---|
स्वरूप: | लेख |
भाषा: | Russian |
प्रकाशित: |
ABV-press
2014-11-01
|
श्रृंखला: | Опухоли женской репродуктивной системы |
विषय: | |
ऑनलाइन पहुंच: | https://ojrs.abvpress.ru/ojrs/article/view/390 |
समान संसाधन
-
Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer
द्वारा: Dandan Song, और अन्य
प्रकाशित: (2021-07-01) -
A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis
द्वारा: Jin Hong, और अन्य
प्रकाशित: (2020-07-01) -
A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
द्वारा: Gu Ran, और अन्य
प्रकाशित: (2012-05-01) -
Three benefits of toremifene, or a trend in the current hormone therapy
द्वारा: E. I. Borisova, और अन्य
प्रकाशित: (2015-12-01) -
High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
द्वारा: Ryutaro Mori, और अन्य
प्रकाशित: (2014-06-01)